14-day Premium Trial Subscription Try For FreeTry Free
Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquir
Gainers Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test. ContraFect Corporation (NASDAQ: CFRX)
Gainers Lucira Health, Inc. (NASDAQ: LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses. Ob

Why Is ObsEva (OBSV) Stock Up 61% Today?

08:37am, Monday, 27'th Feb 2023
ObsEva (NASDAQ: OBSV ) stock is bouncing back on Monday after the company's stock underwent a major dip during the prior day of trading. That crash saw the company's shares fall 50.8% during Friday's
Gainers Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER) shares jumped 129.6% to $10.15. Jeffrey E. Kelter reported a 22.4% stake in a 13D filing on Thursday. Cingulate Inc (NASDAQ: CING) rose 6
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange

Why ObsEva (OBSV) Stock Is Down 36% Today

10:54am, Friday, 24'th Feb 2023
ObsEva (NASDAQ: OBSV ) is trending on social media, and OBSV stock is tumbling 36% to 10.85 cents. The Swiss biopharmaceutical company announced that it would undertake a major reorganization to prese
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. Axcella H
Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in

ObsEva Announces Dismissal of Moratorium Proceedings

06:00am, Monday, 19'th Dec 2022 GlobeNewswire Inc.
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio. Crown ElectroKinetic
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE